Top News

Complete Genomics Sets IPO Pricing Range

Mountain View-based Complete Genomics, a provide of gene sequencing services, has set a pricing range for its IPO. The firm, which is looking to list on the NASDAQ Global Market as GNOM, said it expects its public offering price to be between $12.00 and $14.00 per share. Complete Genomics is venture backed by Essex Woodlands Health Ventures, OrbiMed Advisors, Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners and Highland Capital Management.


 

Marketplace


blog comments powered by Disqus
 

Latest Headlines

Browse Issues